2015 APHA Annual Meeting & Expo

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

334483
Body mass index, lifestyle factors, and migration history among Mexican-American women with and without a family history of breast cancer


Monday, November 2, 2015

Samira Kamrudin, MPH, PHD, Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, TX
Background: Breast cancer (BC) risk is doubled among women with a first-degree family history (FH) of BC, while American Cancer Society (ACS) guidelines are to maintain a healthy weight, engage in moderate/strenuous physical activity for 2.5 hours/week, and limit alcohol consumption to ≤1 drink/day. 

Methods: We evaluated associations among FH, BC risk factors including BMI, lifestyle factors, migration history, and adherence to ACS guidelines in 7279 Mexican-American (MA) women in the Mano a Mano Cohort Study. 

Results: MA women with a FH of BC were older, reported lower levels of adherence to ACS physical activity and BMI guidelines, and had higher BMIs (mean 32.1 vs. 30.8) compared to those without a FH.  Prevalence of FH was higher among US-born women and those residing in the US for 20 years or more compared to Mexican-born women. 

Discussion: Our results suggest that MA women, regardless of their FH risk status, do not practice risk reducing behaviors.

Learning Areas:

Epidemiology

Learning Objectives:
Discuss how family history of breast cancer may have an effect on lifestyle behaviors among Mexican-American women.

Keyword(s): Cancer, Minority Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have completed my dissertation and have studied breast cancer subtypes among Mexican-American women.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3202.0: Poster Session - New Findings in Cancer Research and Public Health Epidemiology